NovaBay Pharmaceuticals Inc (AMEX:NBY)
$ 0.759 -0.0211 (-2.7%) Market Cap: 3.71 Mil Enterprise Value: 5.22 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

NovaBay Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 09, 2023 / 06:00PM GMT
Release Date Price: $23.8 (-1.43%)
Justin Hall
NovaBay Pharmaceuticals, Inc. - CEO, Director & General Counsel

Welcome to the 2023 Annual Meeting of Stockholders of NovaBay Pharmaceuticals. It is now 11:00 AM Pacific Time, and the meeting will please come to order. My name is Justin Hall and as CEO and General Counsel and as a Director, I will preside over this meeting and serve as its Chair and Secretary.

I would now like to introduce you to other members of our Board of Directors and guests: Paul Freiman, Chair of the Board of Directors and Chair of the Compensation Committee; Julie Garlikov, a Director; Swan Sit, a Director; Bob WU, a Director; Jeff Zheng, a Director and Chair of the Audit Committee and Chair of the Nominating and Corporate Governance Committee; and Sean Zheng, a Director.

Also present with us today are Kathryn Wheadon, a representative of Broadridge Financial Solutions who will serve as the Inspector of Elections and Abby Brown, a representative of Squire Patton Boggs, our outside counsel. Today, we will proceed as follows.

First, we will hold our 2023 annual stockholders meeting,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot